Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 20, 2022Molecular Therapy — Nucleic AcidsOpen Access

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models

View Full Paper
Ask AI
Bookmark
Share

Authors

ECElisa CallegariUniversity of FerraraPGPaola GuerrieroUniversity of FerraraCBCristian BassiUniversity of Ferrara

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Callegari et al. (2022) studied this question.

synapsesocial.com/papers/6a22be18b67b8d1b1fd2e59ahttps://doi.org/10.1016/j.omtn.2022.07.015
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells2010 · 397 citations
  2. 2FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer2015 · 387 citations
  3. 3Sorafenib: a clinical and pharmacologic review2010 · 169 citations
  4. 4MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway2020 · 311 citations
  5. 5miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma2016 · 72 citations